Amar Patel

Dr. Amar Patel

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 April 2018 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
ABAlejandro Bilbao
Alejandro Bilbao
APAmar Patel
Amar Patel
MRMizanur Rahman
Mizanur Rahman
SVSiva A. Valapalli
Siva A. Valapalli
JBJerzy Blawzdziewicz
Jerzy Blawzdziewicz
Significance: Investigations of the free-living nematode Caenorhabditis elegans give powerful insights into fundamental biological processes that are conserved across species. Locomotion of this model organism is used to assess muscular and neural defects and score impacts of genetic mutations and pharmacological interventions. Existing analyses of the nematode gait have been focused on 2D locomotion, and 3D motion remains largely unexplored. We identify and mathematically describe a unique 3D behavioral pattern in burrowing and swimming—a roll maneuver—which, in combination with 2D turns, allows the nematode to explore bulk media. Our results provide important insights into 3D neuromuscular actuation and may be used to develop better assays for locomotion phenotype analysis.

1 September 2021 in Journal of the Academy of Consultation-Liaison Psychiatry
Verified
Journal Article
Closed access
MCMichelle A. Camarata
Michelle A. Camarata
AAAftab Ala
Aftab Ala
ACAyse K. Coskun
Ayse K. Coskun
YDYanhong Deng
Yanhong Deng
RGRegino P. Gonzalez-Peralta
Regino P. Gonzalez-Peralta
PZPaula C. Zimbrean
Paula C. Zimbrean

13 October 2021 in Tremor and Other Hyperkinetic Movements
Verified
Journal Article
Open access
PDF file
SMSarah Mancone
Sarah Mancone
CSChindhuri Selvadurai
Chindhuri Selvadurai
JBJoachim Baehring
Joachim Baehring
APAmar Patel
Amar Patel
Human herpesvirus-6 (HHV-6) has been associated with various neurologic disorders, but movement disorders are rare. This case describes a patient who developed a choreoathetotic movement disorder in the setting of HHV-6 infection. A 72-year-old woman with AML and recent HHV-6 encephalitis following stem cell transplant presented with involuntary movements. Neurologic examination demonstrated motor impersistence and irregular non-stereotyped writhing movements consistent with a choreoathetotic movement disorder secondary to HHV-6 infection. This is the first literature reported case of adult-onset chorea associated with HHV-6 infection, though it remains unclear if the movement disorder was from the infection or a secondary autoimmune response.

20 June 2018
Verified
Journal Article
Closed access
APAmar Patel
Amar Patel
WDWissam Deeb
Wissam Deeb
MOMichael S. Okun
Michael S. Okun
Clinical Vignette: A 64-year-old female with essential tremor ( ET) presents for evaluation of deep brain stimulation (DBS) candidacy. Examination revealed subtle dystonic features as well as a disabling postural-action tremor. Clinical Dilemma: Can dystonia occur in the setting of the diagnosis of ET and can its presence alter DBS target selection? Clinical Solution: Unilateral DBS implantation of the ventralis intermedius (Vim) led to improvement in both tremor and dystonic posturing. Gap in Knowledge: Case reports of DBS in dystonic tremor suggest Vim, globus pallidus internus (GPi), and subthalamic targets may all be effective, to varying degrees, in improving both tremor and dystonia. More rigorous studies are needed to identify the optimal target(s). Expert Commentary: This case underscores the limited evidence available to guide a clinician's choice of DBS targets in patients with ET and dystonia. The severity of the dystonia and the presence of more generalized dystonia may alter the thinking about optimal targeting. Vim, GPi, and subthalamic targets appear potentially acceptable options, though Vim is usually the first target attempted when postural-action tremor is the chief complaint. Occasionally, a second rescue DBS lead may be necessary.

21 October 2020 in Tremor and Other Hyperkinetic Movements
Verified
Journal Article
Open access
PDF file
SCShannon Y. Chiu
Shannon Y. Chiu
WDWissam Deeb
Wissam Deeb
PZPamela Zeilman
Pamela Zeilman
Adolfo Ramirez-ZamoraAdolfo Ramirez-Zamora
Adolfo Ramirez-Zamora
APAddie Patterson
Addie Patterson
LALeonardo Almeida
Leonardo Almeida
Clinical vignette: A 51-year-old man with essential tremor (ET) had bilateral ventralis intermedius nucleus deep brain stimulation (VIM-DBS) placed to address refractory tremor. Despite well-placed DBS leads and adequate tremor response, he subsequently experienced worsening. Reprogramming of the device and reconfirming the electrical thresholds for benefits and side effects were both performed. Six years following DBS implantation, repeat imaging revealed brain atrophy and a measured lead position change with a coincident change in clinical response. Clinical dilemma: What do we know about brain atrophy affecting lead placement and long-term DBS effectiveness? What are the potential strategies to combat narrowed therapeutic thresholds and to maximize DBS therapeutic benefit? Clinical solution: Decreasing the electrical field of stimulation and programming in a bipolar configuration are strategies to provide symptomatic tremor control and to minimize stimulation-induced side effects. Gaps in knowledge: Currently, effects of brain atrophy, and factors underpinning emergence of side effects and/or loss of benefit in chronic VIM-DBS remain largely unexplored.

26 August 2021 in JAMA Ophthalmology
Verified
Journal Article
Open access
PDF file
RVRobin A. Vora
Robin A. Vora
APAmar Patel
Amar Patel
MSMichael I. Seider
Michael I. Seider
SYSam Yang
Sam Yang
Question How did cases of wrong intravitreous injection occur within Kaiser Permanente Northern California? Findings In this case series of 4 patients identified over 2 years among more than 147 000 intravitreous injections, inconsistent use of safety practices such as pre-procedural checklists and timeouts were associated with wrong-eye and -medication intravitreous injections. Meaning These cases emphasize the need for implementing and consistently following rigorous measures to decrease the risk of wrong injections. Importance This case series describes events associated with errors in intravitreous injections. Given the volume of injections performed worldwide, it is important to identify the factors associated with these wrong events to try to reduce their occurrences. Objective To evaluate a series of errors in intravitreous injections within Kaiser Permanente Northern California (KPNC). Design, Setting, and Participants In this retrospective small case series of a convenience sample at KPNC between January 1, 2019, and December 30, 2020, cases of errors in intravitreous injection were identified either as part of a formal institutional quality review or by self-report of the involved surgeon during quality improvement discussions. Main Outcomes and Measures Description of the medical errors and the circumstances surrounding these errors. Results During the 2 years of this evaluation, there were more than 147 000 injections performed within KPNC. Four cases of errors in intravitreous injection were identified. Mistakes were associated with inaccurate review of the electronic medical record, poor surgeon and staff focus, and inconsistent use of surgical checklists and timeouts. No long-term ocular morbidity occurred following any of these errors. Conclusions and Relevance Medical errors related to intravitreous injections have occurred within KPNC. We trust these events are not unique to our practice. A standardized teams-based approach that incorporates rigorous safety protocols will likely be needed to reduce the risk of future wrong intravitreous injections. Identify all potential conflicts of interest that might be relevant to your comment. Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. Err on the side of full disclosure. If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response. Not all submitted comments are published. Please see our commenting policy for details.